These results showed that miR-590-3p overexpression and combination of EMAP-II with TMZ significantly suppressed tumor growth in vivo, in addition, miR-590-3p overexpression enhanced the tumor suppressive effect of combination treatment with EMAP-II and TMZ. The gene discussed is AIMP1; the disease is neoplasm.